Medivation Reiterates Rejection Of Sanofi's Inadequate Proposal To Buy It By: Benzinga via Benzinga May 05, 2016 at 13:21 PM EDT Medivation, Inc. (NASDAQ: MDVN) reaffirmed its rejection of Sanofi's (NYSE: SNY) substantially inadequate proposal to buy the ... Read More >> Related Stocks: Macy's Sanofi-Aventis S.A. ADR